The DOI matches its Crossref record; 111 of the 111 references it cites were found in a registry or an index.
Occurrence and transmission potential of asymptomatic and presymptomatic SARS-CoV-2 infections: A living systematic review and meta-analysis
Open accessPublished version of a preprint
Abstract
BACKGROUND There is disagreement about the level of asymptomatic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. We conducted a living systematic review and meta-analysis to address three questions: 1. amongst people who become infected with SARS-CoV-2, what proportion does not experience symptoms at all during their infection? 2. Amongst people with SARS-CoV-2 infection who are asymptomatic when diagnosed, what proportion will develop symptoms later? 3. What proportion of SARS-CoV-2 transmission is accounted for by people who are either asymptomatic throughout infection, or pre-symptomatic? METHODS AND FINDINGS We searched PubMed, Embase, bioRxiv and medRxiv using a database of SARS-CoV-2 literature that is updated daily, on 25 March 2020, 20 April 2020 and 10 June 2020. Studies of people with SARS-CoV-2 diagnosed by reverse transcriptase PCR that documented follow-up and symptom status at the beginning and end of follow-up, or modelling studies were included. One reviewer extracted data and a second verified the extraction, with disagreement resolved by discussion or a third reviewer. Risk of bias in empirical studies was assessed with an adapted checklist for case series and the relevance and credibility of modelling studies were assessed using a published checklist. We included a total of 94 studies. The overall estimate of the proportion of people who become infected with SARS-CoV-2 and remain asymptomatic throughout infection was 20% (95% CI 17-25) with a prediction interval of 3-67% in 79 studies that addressed this review question. There was some evidence that biases in the selection of participants influence the estimate. In seven studies of defined populations screened for SARS-CoV-2 and then followed, 31% (95% CI 26-37%, prediction interval 24-38%) remained asymptomatic. The proportion of people that is pre-symptomatic could not be summarised, owing to heterogeneity. The secondary attack rate was slightly lower in contacts of people with asymptomatic infection than those with symptomatic infection (relative risk 0.35, 95% CI 0.10-1.27). Modelling studies fit to data found a higher proportion of all SARS-CoV-2 infections resulting from transmission from pre-symptomatic individuals than from asymptomatic individuals. Limitations of the review include that most included studies were not designed to estimate the proportion of asymptomatic SARS-CoV-2 infections and were at risk of selection biases, we did not consider the possible impact of false negative RT-PCR results, which would underestimate the proportion of asymptomatic infections, and that the database does not include all sources. CONCLUSIONS The findings of this living systematic review of publications early in the pandemic suggest that most SARS-CoV-2 infections are not asymptomatic throughout the course of infection. The contribution of pre-symptomatic and asymptomatic infections to overall SARS-CoV-2 transmission means that combination prevention measures, with enhanced hand hygiene, masks, testing tracing and isolation strategies and social distancing, will continue to be needed. AUTHOR SUMMARY Why was this study done? ▪ The proportion of people who will remain asymptomatic throughout the course of infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the cause of coronavirus disease 2019 (covid-19), is not known. ▪ Studies that assess people at just one time point will overestimate the proportion of true asymptomatic infection because those who go on to develop covid-19 symptoms will be wrongly classified as asymptomatic, rather than pre-symptomatic. ▪ The amount, and infectiousness, of asymptomatic SARS-CoV-2 infection will determine what kind of measures will prevent transmission most effectively. What did the researchers do and find? ▪ We did a living systematic review through 10 June 2020, using automated workflows that speed up the review processes, and allow the review to be updated when relevant new evidence becomes available. ▪ Overall, in 79 studies in a range of different settings, 20% (95% confidence interval, CI 17–25%) of people with SARS-CoV-2 infection remained asymptomatic during follow-up, but biases in study designs limit the certainty of this estimate. ▪ We found some evidence that SARS-CoV-2 infection in contacts of people with asymptomatic infection is less likely than in contacts of people with symptomatic infection (relative risk 0.35, 95% CI 0.10-1.27). What do these findings mean? ▪ The findings of this living systematic review suggest that most SARS-CoV-2 infections are not asymptomatic throughout the course of infection. ▪ Future studies should be designed specifically to determine the true proportion of asymptomatic SARS-CoV-2 infections, using methods to minimise biases in the selection of study participants and ascertainment of symptom status during follow up. ▪ The contribution of pre-symptomatic and asymptomatic infections to overall SARS-CoV-2 trans
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Liberati, A., Altman, D. G., Tetzlaff, J., Mulrow, C., Gøtzsche, P. C., Ioannidis, J. P. A., Clarke, M., Devereaux, P. J., Kleijnen, J., & Moher, D. (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000100 · Cited by 28,164
Chan, J. F.-W., Yuan, S., Kok, K.-H., To, K. K.-W., Chu, H., Yang, J., Xing, F., Liu, J., Yip, C. C.-Y., Poon, R. W.-S., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30154-9 · Cited by 8,944
How to perform a meta-analysis with R: a practical tutorial
Balduzzi, S., Rücker, G., & Schwarzer, G. (2019) · Evidence Based Mental Health · doi:10.1136/ebmental-2019-300117 · Cited by 5,827
Two-sided confidence intervals for the single proportion: comparison of seven methods
Newcombe, R. G. (1998) · Statistics in Medicine · doi:10.1002/(sici)1097-0258(19980430)17:8<857::aid-sim777>3.0.co;2-e · Cited by 5,107
SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected Patients
Zou, L., Ruan, F., Huang, M., Liang, L., Huang, H., Hong, Z., Yu, J., Kang, M., Song, Y., Xia, J., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmc2001737 · Cited by 4,810
Presumed Asymptomatic Carrier Transmission of COVID-19
Bai, Y., Yao, L., Wei, T., Tian, F., Jin, D.-Y., Chen, L., & Wang, M. (2020) · JAMA · doi:10.1001/jama.2020.2565 · Cited by 4,498
Temporal dynamics in viral shedding and transmissibility of COVID-19
He, X., Lau, E. H. Y., Wu, P., Deng, X., Wang, J., Hao, X., Lau, Y. C., Wong, J. Y., Guan, Y., Tan, X., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0869-5 · Cited by 4,247
Li, R., Pei, S., Chen, B., Song, Y., Zhang, T., Yang, W., & Shaman, J. (2020) · Science · doi:10.1126/science.abb3221 · Cited by 3,633
Interpretation of random effects meta-analyses
Riley, R. D., Higgins, J. P. T., & Deeks, J. J. (2011) · BMJ · doi:10.1136/bmj.d549 · Cited by 2,884
Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections
Long, Q.-X., Tang, X.-J., Shi, Q.-L., Li, Q., Deng, H.-J., Yuan, J., Hu, J.-L., Xu, W., Zhang, Y., Lv, F.-J., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0965-6 · Cited by 2,686
Quantifying SARS-CoV-2 transmission suggests epidemic control with digital contact tracing
Ferretti, L., Wymant, C., Kendall, M., Zhao, L., Nurtay, A., Abeler-Dörner, L., Parker, M., Bonsall, D., & Fraser, C. (2020) · Science · doi:10.1126/science.abb6936 · Cited by 2,512
Systematic review of COVID‐19 in children shows milder cases and a better prognosis than adults
Ludvigsson, J. F. (2020) · Acta Paediatrica · doi:10.1111/apa.15270 · Cited by 2,301
Prevalence of Asymptomatic SARS-CoV-2 Infection: A Narrative Review
Oran, D. P., & Topol, E. J. (2020) · Annals of Internal Medicine · doi:10.7326/m20-3012 · Cited by 2,279
Mizumoto, K., Kagaya, K., Zarebski, A., & Chowell, G. (2020) · Eurosurveillance · doi:10.2807/1560-7917.es.2020.25.10.2000180 · Cited by 2,276
Presymptomatic SARS-CoV-2 Infections and Transmission in a Skilled Nursing Facility
Arons, M. M., Hatfield, K. M., Reddy, S. C., Kimball, A., James, A., Jacobs, J. R., Taylor, J., Spicer, K., Bardossy, A. C., Oakley, L. P., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2008457 · Cited by 2,052
Bi, Q., Wu, Y., Mei, S., Ye, C., Zou, X., Zhang, Z., Liu, X., Wei, L., Truelove, S. A., Zhang, T., et al. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30287-5 · Cited by 1,958
Kucirka, L. M., Lauer, S. A., Laeyendecker, O., Boon, D., & Lessler, J. (2020) · Annals of Internal Medicine · doi:10.7326/m20-1495 · Cited by 1,414
Hu, Z., Song, C., Xu, C., Jin, G., Chen, Y., Xu, X., Ma, H., Chen, W., Lin, Y., Zheng, Y., et al. (2020) · Science China Life Sciences · doi:10.1007/s11427-020-1661-4 · Cited by 1,412
Estimation of the asymptomatic ratio of novel coronavirus infections (COVID-19)
Nishiura, H., Kobayashi, T., Miyama, T., Suzuki, A., Jung, S.-M., Hayashi, K., Kinoshita, R., Yang, Y., Yuan, B., Akhmetzhanov, A. R., et al. (2020) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2020.03.020 · Cited by 1,298
Qiu, H., Wu, J., Hong, L., Luo, Y., Song, Q., & Chen, D. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30198-5 · Cited by 1,283
Defining the Epidemiology of Covid-19 — Studies Needed
Lipsitch, M., Swerdlow, D. L., & Finelli, L. (2020) · New England Journal of Medicine · doi:10.1056/nejmp2002125 · Cited by 1,248
Suppression of a SARS-CoV-2 outbreak in the Italian municipality of Vo’
Lavezzo, E., Franchin, E., Ciavarella, C., Cuomo-Dannenburg, G., Barzon, L., Del Vecchio, C., Rossi, L., Manganelli, R., Loregian, A., Navarin, N., et al. (2020) · Nature · doi:10.1038/s41586-020-2488-1 · Cited by 1,087
Kimball, A., Hatfield, K. M., Arons, M., James, A., Taylor, J., Spicer, K., Bardossy, A. C., Oakley, L. P., Tanwar, S., Chisty, Z., et al. (2020) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6913e1 · Cited by 1,050
Presymptomatic Transmission of SARS-CoV-2 — Singapore, January 23–March 16, 2020
Wei, W. E., Li, Z., Chiew, C. J., Yong, S. E., Toh, M. P., & Lee, V. J. (2020) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6914e1 · Cited by 891
Cheng, H.-Y., Jian, S.-W., Liu, D.-P., Ng, T.-C., Huang, W.-T., Lin, H.-H., & for the Taiwan COVID-19 Outbreak Investigation Team (2020) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2020.2020 · Cited by 860
Antibody tests for identification of current and past infection with SARS‐CoV‐2
Geppert, J., Scandrett, K., Bigio, J., Sulis, G., Hettiarachchi, D., Mathangasinghe, Y., Weeratunga, P., Wickramasinghe, D., Bergman, H., Buckley, S. B., et al. (2022) · LSTM Online Archive (Liverpool School of Tropical Medicine) · Cited by 850
Breslin, N., Baptiste, C., Gyamfi-Bannerman, C., Miller, R., Martinez, R., Bernstein, K., Ring, L., Landau, R., Purisch, S., Friedman, A. M., et al. (2020) · American Journal of Obstetrics & Gynecology MFM · doi:10.1016/j.ajogmf.2020.100118 · Cited by 784
Household Transmission of SARS-CoV-2: A Systematic Review and Meta-analysis
Madewell, Z. J., Yang, Y., Longini, I. M., Halloran, M. E., & Dean, N. E. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.31756 · Cited by 716
(2020) · doi:10.3138/jammi-2020-0030 · Cited by 664
Antibody tests for identification of current and past infection with SARS-CoV-2
Deeks, J. J., Dinnes, J., Takwoingi, Y., Davenport, C., Spijker, R., Taylor-Phillips, S., Adriano, A., Beese, S., Dretzke, J., Ferrante di Ruffano, L., et al. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013652 · Cited by 655
Ganyani, T., Kremer, C., Chen, D., Torneri, A., Faes, C., Wallinga, J., & Hens, N. (2020) · Eurosurveillance · doi:10.2807/1560-7917.es.2020.25.17.2000257 · Cited by 640
Living Systematic Reviews: An Emerging Opportunity to Narrow the Evidence-Practice Gap
Elliott, J. H., Turner, T., Clavisi, O., Thomas, J., Higgins, J. P. T., Mavergames, C., & Gruen, R. L. (2014) · PLoS Medicine · doi:10.1371/journal.pmed.1001603 · Cited by 596
Evidence of SARS-CoV-2 Infection in Returning Travelers from Wuhan, China
Hoehl, S., Rabenau, H., Berger, A., Kortenbusch, M., Cinatl, J., Bojkova, D., Behrens, P., Böddinghaus, B., Götsch, U., Naujoks, F., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmc2001899 · Cited by 578
Covid-19: four fifths of cases are asymptomatic, China figures indicate
Day, M. (2020) · BMJ · doi:10.1136/bmj.m1375 · Cited by 563
Rivett, L., Sridhar, S., Sparkes, D., Routledge, M., Jones, N. K., Forrest, S., Young, J., Pereira-Dias, J., Hamilton, W. L., Ferris, M., et al. (2020) · eLife · doi:10.7554/elife.58728 · Cited by 519
Coronavirus Disease Outbreak in Call Center, South Korea
Park, S. Y., Kim, Y.-M., Yi, S., Lee, S., Na, B.-J., Kim, C. B., Kim, J.-I., Kim, H. S., Kim, Y. B., Park, Y., et al. (2020) · Emerging Infectious Diseases · doi:10.3201/eid2608.201274 · Cited by 467
Potential Presymptomatic Transmission of SARS-CoV-2, Zhejiang Province, China, 2020
Tong, Z.-D., Tang, A., Li, K.-F., Li, P., Wang, H.-L., Yi, J.-P., Zhang, Y.-L., & Yan, J.-B. (2020) · Emerging Infectious Diseases · doi:10.3201/eid2605.200198 · Cited by 463
Böhmer, M. M., Buchholz, U., Corman, V. M., Hoch, M., Katz, K., Marosevic, D. V., Böhm, S., Woudenberg, T., Ackermann, N., Konrad, R., et al. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30314-5 · Cited by 434
Proportion of asymptomatic coronavirus disease 2019: A systematic review and meta‐analysis
He, J., Guo, Y., Mao, R., & Zhang, J. (2021) · Journal of Medical Virology · doi:10.1002/jmv.26326 · Cited by 383
Luo, L., Liu, D., Liao, X., Wu, X., Jing, Q., Zheng, J., Liu, F., Yang, S., Bi, H., Li, Z., et al. (2020) · Annals of Internal Medicine · doi:10.7326/m20-2671 · Cited by 356
Living systematic reviews: 2. Combining human and machine effort
Thomas, J., Noel-Storr, A., Marshall, I., Wallace, B., McDonald, S., Mavergames, C., Glasziou, P., Shemilt, I., Synnot, A., Turner, T., et al. (2017) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2017.08.011 · Cited by 355
Self-citationWang, Y., Liu, Y., Liu, L., Wang, X., Luo, N., & Li, L. (2020) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaa119 · Cited by 321
COVID-19: PCR screening of asymptomatic health-care workers at London hospital
Treibel, T. A., Manisty, C., Burton, M., McKnight, Á., Lambourne, J., Augusto, J. B., Couto-Parada, X., Cutino-Moguel, T., Noursadeghi, M., & Moon, J. C. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31100-4 · Cited by 314
Guidelines for evaluating prevalence studies
Boyle, M. H. (1998) · Evidence Based Mental Health · doi:10.1136/ebmh.1.2.37 · Cited by 313
COVID-19 Transmission Within a Family Cluster by Presymptomatic Carriers in China
Qian, G., Yang, N., Ma, A. H. Y., Wang, L., Li, G., Chen, X., & Chen, X. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa316 · Cited by 302
Tabata, S., Imai, K., Kawano, S., Ikeda, M., Kodama, T., Miyoshi, K., Obinata, H., Mimura, S., Kodera, T., Kitagaki, M., et al. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30482-5 · Cited by 296
Meng, H., Xiong, R., He, R., Lin, W., Hao, B., Zhang, L., Lu, Z., Shen, X., Fan, T., Jiang, W., et al. (2020) · Journal of Infection · doi:10.1016/j.jinf.2020.04.004 · Cited by 276
Yongchen, Z., Shen, H., Wang, X., Shi, X., Li, Y., Yan, J., Chen, Y., & Gu, B. (2020) · Emerging Microbes & Infections · doi:10.1080/22221751.2020.1756699 · Cited by 266
Van Vinh Chau, N., Lam, V. T., Dung, N. T., Yen, L. M., Minh, N. N. Q., Hung, L. M., Ngoc, N. M., Dung, N. T., Man, D. N. H., Nguyet, L. A., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa711 · Cited by 243
Vaira, L. A., Hopkins, C., Salzano, G., Petrocelli, M., Melis, A., Cucurullo, M., Ferrari, M., Gagliardini, L., Pipolo, C., Deiana, G., et al. (2020) · Head & Neck · doi:10.1002/hed.26269 · Cited by 239
SARS-CoV-2 infection, clinical features and outcome of COVID-19 in United Kingdom nursing homes
Graham, N. S. N., Junghans, C., Downes, R., Sendall, C., Lai, H., McKirdy, A., Elliott, P., Howard, R., Wingfield, D., Priestman, M., et al. (2020) · Journal of Infection · doi:10.1016/j.jinf.2020.05.073 · Cited by 239
Cluster of Coronavirus Disease 2019 (COVID-19) in the French Alps, February 2020
Danis, K., Epaulard, O., Bénet, T., Gaymard, A., Campoy, S., Botelho-Nevers, E., Bouscambert-Duchamp, M., Spaccaferri, G., Ader, F., Mailles, A., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa424 · Cited by 232
Wang, X., Fang, J., Zhu, Y., Chen, L., Ding, F., Zhou, R., Ge, L., Wang, F., Chen, Q., Zhang, Y., et al. (2020) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2020.03.032 · Cited by 231
Delivery of infection from asymptomatic carriers of COVID-19 in a familial cluster
Ye, F., Xu, S., Rong, Z., Xu, R., Liu, X., Deng, P., Liu, H., & Xu, X. (2020) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2020.03.042 · Cited by 230
Viral dynamics in asymptomatic patients with COVID-19
Zhou, R., Li, F., Chen, F., Liu, H., Zheng, J., Lei, C., & Wu, X. (2020) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2020.05.030 · Cited by 229
Peak, C. M., Kahn, R., Grad, Y. H., Childs, L. M., Li, R., Lipsitch, M., & Buckee, C. O. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30361-3 · Cited by 220
Household transmission of SARS-CoV-2
Wang, Z., Ma, W., Zheng, X., Wu, G., & Zhang, R. (2020) · Journal of Infection · doi:10.1016/j.jinf.2020.03.040 · Cited by 219
Yang, R., Gui, X., & Xiong, Y. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.10182 · Cited by 203
Antibody tests for identification of current and past infection with SARS-CoV-2
Fox, T., Geppert, J., Dinnes, J., Scandrett, K., Bigio, J., Sulis, G., Hettiarachchi, D., Mathangasinghe, Y., Weeratunga, P., Wickramasinghe, D., et al. (2022) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013652.pub2 · Cited by 199
Severe Acute Respiratory Syndrome Coronavirus 2 RNA Detected in Blood Donations
Chang, L., Zhao, L., Gong, H., Wang, L., & Wang, L. (2020) · Emerging Infectious Diseases · doi:10.3201/eid2607.200839 · Cited by 177
Jaime Caro, J., Eddy, D. M., Kan, H., Kaltz, C., Patel, B., Eldessouki, R., & Briggs, A. H. (2014) · Value in Health · doi:10.1016/j.jval.2014.01.003 · Cited by 171
Clinical features of pediatric patients with coronavirus disease (COVID-19)
Song, W., Li, J., Zou, N., Guan, W., Pan, J., & Xu, W. (2020) · Journal of Clinical Virology · doi:10.1016/j.jcv.2020.104377 · Cited by 153
The Relationship between Status at Presentation and Outcomes among Pregnant Women with COVID-19
London, V., McLaren, R. A., Atallah, F., Cepeda, C., McCalla, S., Fisher, N., Stein, J. L., Haberman, S., & MINKOFF, H. L. (2020) · American Journal of Perinatology · doi:10.1055/s-0040-1712164 · Cited by 138
Epidemiological and Clinical Characteristics of COVID-19 in Adolescents and Young Adults
Liao, J., Fan, S., Chen, J., Wu, J., Xu, S., Guo, Y., Li, C., Zhang, X., Wu, C., Mou, H., et al. (2020) · The Innovation · doi:10.1016/j.xinn.2020.04.001 · Cited by 137
Household Transmission of SARS-CoV-2, Zhuhai, China, 2020
Wu, J., Huang, Y., Tu, C., Bi, C., Chen, Z., Luo, L., Huang, M., Chen, M., Tan, C., Wang, Z., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa557 · Cited by 137
Lombardi, A., Consonni, D., Carugno, M., Bozzi, G., Mangioni, D., Muscatello, A., Castelli, V., Palomba, E., Cantù, A. P., Ceriotti, F., et al. (2020) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2020.06.013 · Cited by 133
Schwierzeck, V., König, J. C., Kühn, J., Mellmann, A., Correa-Martínez, C. L., Omran, H., Konrad, M., Kaiser, T., & Kampmeier, S. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa491 · Cited by 125
Tan, Y.-P., Tan, B.-Y., Pan, J. H., Wu, J., Zeng, S., & Wei, H. (2020) · Journal of Clinical Virology · doi:10.1016/j.jcv.2020.104353 · Cited by 124
Andrikopoulou, M., Madden, N., Wen, T., Aubey, J. J., Aziz, A., Baptiste, C. D., Breslin, N., D’Alton, M. E., Fuchs, K. M., Goffman, D., et al. (2020) · Obstetrics and Gynecology · doi:10.1097/aog.0000000000003996 · Cited by 123
Jiang, X., Luo, M., Zou, Z., Wang, X., Chen, C., & Qiu, J. (2020) · Journal of Medical Virology · doi:10.1002/jmv.25941 · Cited by 120
Follow-up of asymptomatic patients with SARS-CoV-2 infection
Zhou, X., Li, Y., Li, T., & Zhang, W. (2020) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2020.03.024 · Cited by 118
Viral kinetics of SARS-CoV-2 in asymptomatic carriers and presymptomatic patients
Kim, S. E., Jeong, H. S., Yu, Y., Shin, S. U., Kim, S., Oh, T. H., Kim, U. J., Kang, S., Jang, H., Jung, S., et al. (2020) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2020.04.083 · Cited by 118
Dora, A. V., Winnett, A. V., Jatt, L. P., Davar, K., Watanabe, M., Sohn, L., Kern, H. S., Graber, C. J., & Goetz, M. B. (2020) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6921e1 · Cited by 118
Wang, Y., He, Y., Tong, J., Qin, Y., Xie, T., Li, J.-H., Lǐ, J., Xiang, J., Cui, Y., Higgs, E. S., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa629 · Cited by 116
Roxby, A. C., Greninger, A. L., Hatfield, K. M., Lynch, J. B., Dellit, T. H., James, A. E., Taylor, J., Page, L. C., Kimball, A. A., Arons, M. M., et al. (2020) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2020.2233 · Cited by 113
Familial cluster of COVID-19 infection from an asymptomatic
Zhang, J., Tian, S., Lou, J., & Chen, Y. (2020) · Critical Care · doi:10.1186/s13054-020-2817-7 · Cited by 111
Lü, Y., Li, Y., Deng, W., Liu, M., He, Y., Huang, L., Lv, M., Li, J., & Du, H. (2020) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000002729 · Cited by 96
Emery, J. C., Russell, T., Liu, Y., Hellewell, J., Pearson, C. A. B., CMMID COVID-19 Working Group, Atkins, K. E., Klepac, P., Endo, A., Jarvis, C. I., et al. (2020) · eLife · doi:10.7554/elife.58699 · Cited by 94
Noh, J. Y., Yoon, J. G., Seong, H., Choi, W. S., Sohn, J. W., Cheong, H. J., Kim, W. J., & Song, J. Y. (2020) · Journal of Infection · doi:10.1016/j.jinf.2020.05.035 · Cited by 93
Positive rectal swabs in young patients recovered from coronavirus disease 2019 (COVID-19)
Zhang, B., Liu, S., Dong, Y., Zhang, L., Zhong, Q., Zou, Y., & Zhang, S. (2020) · Journal of Infection · doi:10.1016/j.jinf.2020.04.023 · Cited by 90
Analysis of SARS-CoV-2 Transmission in Different Settings, Brunei
Chaw, L., Koh, W. C., Jamaludin, S. A., Naing, L., Alikhan, M. F., & Wong, J. (2020) · Emerging infectious diseases · doi:10.3201/eid2611.202263 · Cited by 90
Presymptomatic transmission of SARS-CoV-2 infection: a secondary analysis using published data
Casey-Bryars, M., Griffin, J., McAloon, C. G., Byrne, A. W., Madden, J. M., McEvoy, D., Collins, Á. B., Hunt, K., Barber, A. M., Butler, F., et al. (2021) · BMJ Open · doi:10.1136/bmjopen-2020-041240 · Cited by 89
Thái, P. Q., Rabaa, M. A., Luong, D. H., Tan, D. Q., Quang, T. D., Quach, H., Thi, N.-A. H., Dinh, P. C., Nghia, N. D., Tú, T. A., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa1130 · Cited by 86
Jiang, X., Zhang, X., Zhao, X.-N., Li, C.-B., Lei, J., Kou, Z., Sun, W., Yang, H., Gao, F., Ji, S., et al. (2020) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaa206 · Cited by 84
SARS-CoV-2 infection in Spanish children with chronic kidney pathologies
Melgosa, M., Madrid, Á., Alvarez, O. G., Lumbreras, J., Nieto-Vega, F. A., Parada, E., & Pérez-Beltrán, V. (2020) · Pediatric Nephrology · doi:10.1007/s00467-020-04597-1 · Cited by 82
Secondary Transmission of Coronavirus Disease from Presymptomatic Persons, China
Zhang, W., Cheng, W., Luo, L., Ma, Y., Xu, C., Qin, P., & Zhang, Z. (2020) · Emerging infectious diseases · doi:10.3201/eid2608.201142 · Cited by 80
Early Viral Clearance and Antibody Kinetics of COVID-19 Among Asymptomatic Carriers
Xiao, T., Wang, Y., Yuan, J., Ye, H., Wei, L., Liao, X., Wang, H., Qian, S., Wang, Z., Liu, L., et al. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.595773 · Cited by 75
Clinical Analysis of 25 COVID-19 Infections in Children
Bai, K., Liu, W., Liu, C., Fu, Y., Hu, J., Qin, Y., Zhang, Q., Chen, H., Xu, F., & Li, C. (2020) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000002740 · Cited by 74
In-flight transmission cluster of COVID-19: a retrospective case series
Yang, N., Shen, Y., Shi, C., Ma, A. H. Y., Zhang, X., Jian, X., Wang, L., Shi, J., Wu, C., Li, G., et al. (2020) · Scandinavian Journal of Infectious Diseases · doi:10.1080/23744235.2020.1800814 · Cited by 73
Symptoms and immunoglobulin development in hospital staff exposed to a SARS‐CoV‐2 outbreak
Brandstetter, S., Roth, S., Harner, S., Buntrock‐Döpke, H., Toncheva, A. A., Borchers, N. S., Gruber, R., Ambrosch, A., & Kabesch, M. (2020) · Pediatric Allergy and Immunology · doi:10.1111/pai.13278 · Cited by 71
Clinical Characteristics of Patients Hospitalized with Coronavirus Disease, Thailand
Pongpirul, W. A., Mott, J. A., Woodring, J., Uyeki, T. M., MacArthur, J. R., Vachiraphan, A., Suwanvattana, P., Uttayamakul, S., Chunsuttiwat, S., Chotpitayasunondh, T., et al. (2020) · Emerging infectious diseases · doi:10.3201/eid2607.200598 · Cited by 69
SARS-CoV-2 Transmission from Presymptomatic Meeting Attendee, Germany
Hijnen, D., Marzano, A. V., Eyerich, K., GeurtsvanKessel, C. H., Giménez‐Arnau, A. M., Joly, P., Vestergaard, C., Sticherling, M., & Schmidt, E. (2020) · Emerging infectious diseases · doi:10.3201/eid2608.201235 · Cited by 67
Qiu, C., Deng, Z., Xiao, Q., Shu, Y., Deng, Y., Wang, H., Liao, X., Liu, H., Zhou, D., Zhao, X., et al. (2020) · Journal of Medical Virology · doi:10.1002/jmv.25975 · Cited by 64
Asymptomatic and presymptomatic transmission of SARS-CoV-2: A systematic reviewPreprint
Savvides, C. S., & Siegel, R. (2020) · medRxiv · doi:10.1101/2020.06.11.20129072 · Cited by 62
Lytras, T., Dellis, G., Flountzi, A., Hatzianastasiou, S., Nikolopoulou, G. B., Tsekou, K., Diamantis, Z., Stathopoulou, G., Togka, M., Gerolymatos, G., et al. (2020) · Journal of Travel Medicine · doi:10.1093/jtm/taaa054 · Cited by 61
Merza, M. A., Al-Mezori, A., Mohammed, H. M., & Abdulah, D. M. (2020) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2020.04.047 · Cited by 59
Severe Acute Respiratory Syndrome Coronavirus 2 Shedding by Travelers, Vietnam, 2020
Le, T. Q. M., Takemura, T., Moi, M. L., Nabeshima, T., Nguyen, L. K. H., Hoang, V. M. P., Ung, T. T. H., Le, T. T., Nguyen, V. S., Pham, H. Q. A., et al. (2020) · Emerging infectious diseases · doi:10.3201/eid2607.200591 · Cited by 56
Transmission onset distribution of COVID-19
Chun, J. Y., Baek, G., & Kim, Y. (2020) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2020.07.075 · Cited by 53
Epidemiological and clinical features of asymptomatic patients with SARS‐CoV‐2 infection
Xu, T., Huang, R. Q., Zhu, L., Wang, J., Cheng, J., Zhang, B., Zhao, H., Chen, K., Shao, H., Zhu, C., et al. (2020) · Journal of Medical Virology · doi:10.1002/jmv.25944 · Cited by 50
A research agenda for digital proximity tracing apps
von Wyl, V., Bonhoeffer, S., Bugnion, E., Puhan, M. A., Salathé, M., Stadler, T., Troncoso, C., Vayena, E., & Low, N. N. (2020) · Swiss Medical Weekly · doi:10.4414/smw.2020.20324 · Cited by 48
Self-citationHigh proportion of asymptomatic and presymptomatic COVID-19 infections in air passengers to Brunei
Wong, J., Aziz, A. B. Z. A., Chaw, L., Mahamud, A. S., Griffith, M., Lo, Y.-R. J., & Naing, L. (2020) · Journal of Travel Medicine · doi:10.1093/jtm/taaa066 · Cited by 47
Vaira, L. A. (2020) · doi:10.22541/au.158879175.53282134 · Cited by 46
Beale, S., Hayward, A. C., Shallcross, L. J., Aldridge, R. W., & Fragaszy, E. (2020) · Wellcome Open Research · doi:10.12688/wellcomeopenres.16387.1 · Cited by 36
Antibody Profiling of COVID-19 Patients in an Urban Low-Incidence Region in Northern Germany
Solbach, W., Schiffner, J., Backhaus, I., Burger, D., Staiger, R., Tiemer, B., Bobrowski, A., Hutchings, T., & Mischnik, A. (2020) · Frontiers in Public Health · doi:10.3389/fpubh.2020.570543 · Cited by 33
Arima, Y., Kutsuna, S., Shimada, T., Suzuki, M., Suzuki, T., Kobayashi, Y., Tsuchihashi, Y., Nakamura, H., Matsumoto, K., Takeda, A., et al. (2020) · Emerging infectious diseases · doi:10.3201/eid2607.200994 · Cited by 32
Alshami, A., Alattas, R. A., Anan, H., Qahtani, H. A., Alahilm, A., Al-Mulhim, M., & Al-Faraj, A. (2020) · PLoS ONE · doi:10.1371/journal.pone.0241258 · Cited by 28
Characteristics and Outcomes of Hospitalized Young Adults with Mild Covid-19Preprint
Sharma, A. K., Ahmed, A., Baig, V. N., Dhakar, P., Dalela, G., Kacker, S., Panwar, V. R., Panwar, R. B., & Gupta, R. (2020) · medRxiv · doi:10.1101/2020.06.02.20106310 · Cited by 26
Choe, P. G., Kang, E., Lee, S. Y., Oh, B., Im, D., Lee, H., Jung, H., Kang, C. K., Kim, M. S., Park, W. B., et al. (2020) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2020.159 · Cited by 22
Zhang, W. (2020) · medRxiv · doi:10.1101/2020.04.02.20051318 · Cited by 17
Tian, S., Wu, M., Chang, Z., Wang, Y., Zhou, G., Zhang, W., Xing, J., Tian, H., Zhang, X., Zou, X., et al. (2021) · BMC Public Health · doi:10.1186/s12889-021-10713-z · Cited by 16
Kumar, R., Bhattacharya, B., Meena, V. P., Aggarwal, A., Tripathi, M., Soneja, M., Mittal, A., Singh, K., Gupta, N., Garg, R. K., et al. (2020) · Journal of Family Medicine and Primary Care · doi:10.4103/jfmpc.jfmpc_1198_20 · Cited by 11
Research works printed but not linked: 31
- 2017, Rapid Reviews to Strengthen Health Policy and Systems: A Practical Guide
- Buitrago-Garcia D, Egli-Gany D, Counotte M, Hossmann S, Imeri H, Salanti G, et al. The Role of Asymptomatic Sars-Cov-2 Infections: Rapid Living Systematic Review and Meta-Analysis. Version 1. medRxiv [Preprint]. 2020 [cited 2020 Jul 27]. Available from: https://doi.org/10.1101/2020.04.25.20079103 · DOI
- Buitrago-Garcia D, Egli-Gany D, Counotte M, Hossmann S, Imeri H, Salanti G, et al. The Role of Asymptomatic Sars-Cov-2 Infections: Rapid Living Systematic Review and Meta-Analysis. Version 2. medRxiv [Preprint]. 2020 [cited 2020 Jul 27]. Available from: https://doi.org/10.1101/2020.04.25.20079103 · DOI
- M Counotte, 2020, Covid-19 Living Evidence. Bern: Institute of Social and Preventive Medicine
- JF Chan, 2019, Novel Coronavirus Indicating Person-to-Person Transmission: A Study of a Family Cluster, Lancet, 395, 514
- SH Luo, 2020, A Confirmed Asymptomatic Carrier of 2019 Novel Coronavirus, Chin Med J (Engl), 133, 1123, 10.1097/CM9.0000000000000798 · doi:10.1097/cm9.0000000000000798
- Tabata S, Imai K, Kawano S, Ikeda M, Kodama T, Miyoshi K, et al. Non-Severe Vs Severe Symptomatic Covid-19: 104 Cases from the Outbreak on the Cruise Ship 'Diamond Princess' in Japan. medRxiv [Preprint]. 2020 [cited 2020 Jul 27]. doi: 10.1101/2020.03.18.20038125 · DOI
- Luo L, Liu D, Liao X-l, Wu X-b, Jing Q-l, Zheng J-z, et al. Modes of Contact and Risk of Transmission in Covid-19 among Close Contacts. bioRxiv [Preprint]. 2020 [cited 2020 Jul 27]. Available from: https://www.medrxiv.org/content/10.1101/2020.03.24.20042606v1 · DOI
- KC See, 2020, Covid-19: Four Paediatric Cases in Malaysia, Int J Infect Dis, 94, 125, 10.1016/j.ijid.2020.03.049 · DOI
- Tian S, Wu M, Chang Z, Wang Y, Zhou G, Zhang W, et al. Epidemiological Investigation and Intergenerational Clinical Characteristics of 24 Covid-19 Patients Associated with Supermarket Cluster. bioRxiv [Preprint]. 2020 [cited 2020 Jul 27]. doi: 10.1101/2020.04.11.20058891 · doi:10.1101/2020.04.11.20058891
- Y Wang, 2020, Clinical Outcome of 55 Asymptomatic Cases at the Time of Hospital Admission Infected with Sars-Coronavirus-2 in Shenzhen, China, J Infect Dis
- HO Al-Shamsi, 2020, Screening for Covid-19 in Asymptomatic Patients with Cancer in a Hospital in the United Arab Emirates, JAMA Oncol
- K Bai, 2020, Clinical Analysis of 25 Novel Coronavirus Infections in Children, Pediatr Infect Dis J
- Casey M, Griffin J, McAloon CG, Byrne AW, Madden JM, McEvoy D, et al. Estimating Pre-Symptomatic Transmission of Covid-19: A Secondary Analysis Using Published Data. medRxiv [Preprint]. 2020 [cited 2020 Jul 27]. doi: 10.1101/2020.05.08.20094870 · DOI
- Chang MC, Hur J, Park D. Chest Computed Tomography Findings in Asymptomatic Patients with Covid-19. medRxiv [Preprint]. 2020 [cited 2020 Jul 27]. doi: 10.1101/2020.05.09.20096370 · doi:10.1101/2020.05.09.20096370
- Y Gao, 2020, A Cluster of the Corona Virus Disease 2019 Caused by Incubation Period Transmission in Wuxi, China, J Infect
- L Huang, 2020, Initial Ct Imaging Characters of an Imported Family Cluster of Covid-19, Clin Imaging
- R Huang, 2020, A Family Cluster of Covid-19 Involving an Asymptomatic Case with Persistently Positive Sars-Cov-2 in Anal Swabs, Travel Med Infect Dis
- XL Jiang, 2020, Transmission Potential of Asymptomatic and Paucisymptomatic Sars-Cov-2 Infections: A Three-Family Cluster Study in China, J Infect Dis
- W Kong, 2020, Comparison of Clinical and Epidemiological Characteristics of Asymptomatic and Symptomatic Sars-Cov-2 Infection: A Multi-Center Study in Sichuan Province, China, Travel Med Infect Dis
- Kumar R, Bhattacharya B, Meena VP, Aggarwal A, Tripathi M, Soneja M, et al. Management of Mild Covid-19: Policy Implications of Initial Experience in India. medRxiv [Preprint]. 2020 [cited 2020 Jul 27]. doi: 10.1101/2020.05.20.20107664 · doi:10.1101/2020.05.20.20107664
- Y Luo, 2020, Asymptomatic Sars-Cov-2 Infection in Household Contacts of a Healthcare Provider, Wuhan, China, Emerg Infect Dis
- Y Ma, 2020, Characteristics of Asymptomatic Patients with Sars-Cov-2 Infection in Jinan, China. Microbes Infect
- X Tan, 2020, Clinical Features of Children with Sars-Cov-2 Infection: An Analysis of 13 Cases from Changsha, China, Zhongguo Dang Dai Er Ke Za Zhi
- Pham TQ, Rabaa MA, Duong LH, Dang TQ, Tran QD, Quach HL, et al. The First 100 Days of Sars-Cov-2 Control in Vietnam. medRxiv [Preprint]. 2020 [cited 2020 Jul 27]. doi: 10.1101/2020.05.12.20099242 · doi:10.1101/2020.05.12.20099242
- Y Wang, 2020, Characterization of an Asymptomatic Cohort of Sars-Cov-2 Infected Individuals Outside of Wuhan, China, Clin Infect Dis
- HP Wu, 2020, Clinical Features of Coronavirus Disease 2019 in Children Aged <18 Years in Jiangxi, China: An Analysis of 23 Cases, Zhongguo Dang Dai Er Ke Za Zhi, 22, 419
- Xu H, Liu E, Xie J, Smyth R, Zhou Q, Zhao R, et al. A Follow-up Study of Children Infected with Sars-Cov-2 from Western China. medRxiv [Preprint]. 2020 [cited 2020 Jul 27]. doi: 10.1101/2020.04.20.20073288 · doi:10.1101/2020.04.20.20073288
- Zhang W, Long Q, Huang Y, Chen C, Wu J, Hong Y, et al. Asymptomatic Covid-19 Have Longer Treatment Cycle Than Moderate Type of Confirmed Patients. medRxiv [Preprint]. 2020 [cited 2020 Jul 27]. doi: 10.1101/2020.05.16.20103796 · doi:10.1101/2020.05.16.20103796
- NVV Chau, 2020, The Natural History and Transmission Potential of Asymptomatic Sars-Cov-2 Infection, Clin Infect Dis
- C Heneghan, 2020, Covid-19: What Proportion Are Asymptomatic?
Cited by
SARS-CoV-2 Transmission From People Without COVID-19 Symptoms
Johansson, M. A., Quandelacy, T. M., Kada, S., Prasad, P. V., Steele, M., Brooks, J. T., Slayton, R. B., Biggerstaff, M., & Butler, J. C. (2021) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.35057 · Cited by 1,025
Mapping the human genetic architecture of COVID-19
Initiative, C.-1. H. G., InitiativeLeadership, C.-1. H. G., Niemi, M. E. K., Karjalainen, J., Liao, R. G., Neale, B. M., Daly, M., Ganna, A., Writing group, Writing group leaders, et al. (2021) · Nature · doi:10.1038/s41586-021-03767-x · Cited by 983
Sallis, R., Young, D. R., Tartof, S. Y., Sallis, J. F., Sall, J., Li, Q., Smith, G. N., & Cohen, D. A. (2021) · British Journal of Sports Medicine · doi:10.1136/bjsports-2021-104080 · Cited by 789
Miller, S. L., Nazaroff, W. W., Jimenez, J. L., Boerstra, A., Buonanno, G., Dancer, S. J., Kurnitski, J., Marr, L. C., Morawska, L., & Noakes, C. (2021) · Indoor Air · doi:10.1111/ina.12751 · Cited by 734
Virology, transmission, and pathogenesis of SARS-CoV-2
Cevik, M., Kuppalli, K., Kindrachuk, J., & Peiris, M. (2020) · BMJ · doi:10.1136/bmj.m3862 · Cited by 732
Metadata
- Authors
- Buitrago-Garcia, D., Egli-Gany, D., Counotte, M. J., Hossmann, S., Imeri, H., Ipekci, A. M., Salanti, G., & Low, N.
- Venue
- PLOS Medicine
- Publisher
- Public Library of Science (PLoS)
- Published
- 2020-09-22
- Volume
- 17
- Issue
- 9
- Pages
- e1003346
- ISSN
- 1549-1277 (ISSN-L)
- 1549-1676
- OpenAlex
- W3087248341
- Cited by
- 1,000
- References
- 111
- FWCI
- 8.52
- Type
- journal article
- Language
- en
- Open access
- gold
- Funders
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (320030_176233)
- European Union Horizon 2020 research and innovation programme (101003688)
- Swiss Government Excellence Scholarship (2019.0774)
- Swiss School of Public Health plus
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.